Search / Trial NCT06235957

Three Weeks of Cast Immobilisation Versus One Week of Brace Immobilisation in Distal Radius Fractures

Launched by SPAARNE GASTHUIS · Jan 31, 2024

Trial Information

Current as of October 03, 2024

Not yet recruiting

Keywords

Distal Radial Fractures Non Operative Treatment Immobilisation Period

Description

Background: Currently, non- or minimally displaced distal radius fractures are treated by three to five weeks of cast immobilisation. Many patients with a distal radius fracture suffer from long-term functional restrictions, which might be related to stiffness due to cast immobilisation. Current literature indicates that one week of immobilisation might be safe, however, no level one evidence is available. This trial aims to compare one week of brace immobilisation with three weeks of cast immobilisation in patients with distal radius fractures that do not need reduction. Methods: The aim ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. 18-50 years (to eliminate osteoporosis);
  • 2. Primary non- or minimally displaced DRF;
  • 3. Independent for activities of daily living.
  • Exclusion Criteria:
  • 1. Fracture of the contralateral wrist;
  • 2. Ipsilateral fractures, proximal of the DRF;
  • 3. Pre-existent abnormalities or functional deficits of the fractured wrist;
  • 4. Open fractures;
  • 5. Polytrauma patients
  • 6. Language disability to understand the Dutch patient information and questionnaires.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Haarlem, Noord Holland, Netherlands

Rotterdam, Zuid Holland, Netherlands

Amsterdam, Noord Holland, Netherlands

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0